Kemula Pierre Thadee Victor Insider Trades & Stock Holdings

Chief Financial Officer · AgomAb Therapeutics NV · Latest filing Oct 6, 2026

Kemula Pierre Thadee Victor, Chief Financial Officer at AgomAb Therapeutics NV has 1 Form 4 trade on file since Oct 6, 2026. Open-market activity: 1 purchase ($85.94K) and 0 sales ($0), net +$85.94K. Latest filing: acquired 10K shares of $AGMB on Oct 6, 2026 at $8.59.

Trades on file

1

Open-market bought

$85.94K

Open-market sold

$0

Net open-market

+$85.94K

Latest filing

Oct 6, 2026

All insider trades by Kemula Pierre Thadee Victor

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 6, 2026	$AGMB	Buy (Open-market buy)	10K	$8.59	$85.94K			-0.3%			Chief Financial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Kemula Pierre Thadee Victor traded

• $AGMB

Frequently asked questions

Has Kemula Pierre Thadee Victor been buying or selling stock?

Kemula Pierre Thadee Victor has 1 open-market purchase and 0 open-market sales on file, net +$85.94K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Kemula Pierre Thadee Victor's latest insider trade?

acquired 10K shares of $AGMB on Oct 6, 2026 at $8.59.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.